New AI-driven research demonstrated models that generate protein structures in motion with atomic-level detail, aiming to capture both static folding and dynamic behavior important for drug and antibody development. The work focuses on the challenge that many therapeutics bind to proteins whose functional conformations shift over time. By producing full, time-resolved models rather than only equilibrium snapshots, the approach can support downstream efforts such as predicting binding modes, conformational selection, and potentially engineering targets more efficiently. The research also reflects how protein modeling is moving toward higher-fidelity, dynamics-aware representations. For biotech teams, dynamic structure prediction is increasingly relevant for selection of protein therapeutics, antibody development, and designing molecules that work against relevant conformational states.